Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA

Clinical trial NCT03030937 · UNKNOWN

Trial details

NCT number: NCT03030937
Sponsor: Fujian Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction

Start date: 2017-02-01
Primary completion: 2018-07-31
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.